Chapter | No | Status | Audits Passed | Notes | Chapter Page | Part | Last Reviewed | Evidence Level | Last Updated |
|---|---|---|---|---|---|---|---|---|---|
59 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
69 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
87 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
65 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
108 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
70 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
79 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
90 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
86 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
72 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
80 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
76 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
56 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
58 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
57 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
107 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
92 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
112 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
62 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
111 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
74 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
103 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
104 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
84 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
101 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
89 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
105 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
78 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
75 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
102 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
64 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
66 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
82 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
106 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
110 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
73 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
54 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
109 | Not started | XIV Appendices | Sep 6, 2026 8:28 AM | ||||||
71 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
83 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
81 | Not started | XII Advanced Strategies | Sep 6, 2026 8:28 AM | ||||||
55 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
53 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
91 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
88 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
60 | Not started | IX General ICU | Sep 6, 2026 8:28 AM | ||||||
61 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
63 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
68 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
67 | Not started | X Special Populations | Sep 6, 2026 8:28 AM | ||||||
77 | Not started | XI Ethics | Sep 6, 2026 8:28 AM | ||||||
85 | Not started | XIII Handbook | Sep 6, 2026 8:28 AM | ||||||
11 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
15 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
35 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
3 | Published | ClinicalPhysiologyEvidenceCitationNumericalSafetyContradictionRedundancyBedside utilityLiterature update | Published 6 Sep 2026. Completes Part I. Three verified sources (Simons 2024 Perfusion; Parker 2023 Sci Rep; Brasseur 2018 JTD) plus four project texts. Audit correction: the ELSO Red Book text in the project library states '1 Fr = 3 mm', which is wrong; chapter uses the correct 3 Fr = 1 mm and flags the discrepancy. States explicitly that no randomised comparison of ECMO configurations exists. Cannula technique deferred to Ch 5/12; hybrids in depth to Ch 78; ECCO2R to Ch 53. | I Foundations | September 6, 2026 | PhysiologicalObservationalMeta-analysisExpert opinion | Sep 6, 2026 9:03 AM | ||
9 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
6 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
8 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
42 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
5 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
39 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
50 | Not started | VIII Pharmacology | Sep 6, 2026 8:28 AM | ||||||
10 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
44 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
17 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
43 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
46 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
26 | Not started | V Monitoring | Sep 6, 2026 8:28 AM | ||||||
32 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
33 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
37 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
14 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
1 | Published | ClinicalPhysiologyEvidenceCitationNumericalSafetyContradictionRedundancyBedside utilityLiterature update | Published 6 Sep 2026. Open item: CESAR DOI/PMID flagged [VERIFICATION REQUIRED] — publisher and PubMed pages blocked during the search cycle; results transcribed from a published trial summary. Re-verify against the original Lancet 2009 paper. ELSO general guidelines still v1.4 (Aug 2017); adult cardiac guidance (Aug 2021) predates ECLS-SHOCK. | I Foundations | September 6, 2026 | GuidelinesRCTMeta-analysisRegistryPhysiological | Sep 6, 2026 8:40 AM | ||
36 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
7 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
16 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
47 | Not started | VIII Pharmacology | Sep 6, 2026 8:28 AM | ||||||
21 | Not started | IV ECPR | Sep 6, 2026 8:28 AM | ||||||
13 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
23 | Not started | IV ECPR | Sep 6, 2026 8:28 AM | ||||||
18 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
22 | Not started | IV ECPR | Sep 6, 2026 8:28 AM | ||||||
34 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
45 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
28 | Not started | V Monitoring | Sep 6, 2026 8:28 AM | ||||||
38 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
29 | Not started | V Monitoring | Sep 6, 2026 8:28 AM | ||||||
52 | Not started | VIII Pharmacology | Sep 6, 2026 8:28 AM | ||||||
30 | Not started | V Monitoring | Sep 6, 2026 8:28 AM | ||||||
51 | Not started | VIII Pharmacology | Sep 6, 2026 8:28 AM | ||||||
24 | Not started | IV ECPR | Sep 6, 2026 8:28 AM | ||||||
20 | Not started | IV ECPR | Sep 6, 2026 8:28 AM | ||||||
41 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
25 | Not started | V Monitoring | Sep 6, 2026 8:28 AM | ||||||
4 | Not started | II VV ECMO | Sep 6, 2026 8:28 AM | ||||||
31 | Not started | VI Circuit Complications | Sep 6, 2026 8:28 AM | ||||||
2 | Published | ClinicalPhysiologyEvidenceCitationNumericalSafetyContradictionRedundancyBedside utilityLiterature update | Published 6 Sep 2026. Mostly mechanistic content; two cited sources (Ronco 1993 JAMA; Tomarchio 2024 Perfusion) both fully verified. Numerical audit corrected the VO2 index range to 120-130 mL/min/m2 for internal consistency with ~200-250 mL/min. Lieberman critical-DO2-in-conscious-humans study could not be retrieved (Europe PMC rate limiting) and is deliberately not cited. Deliberately does not repeat the CaO2 arithmetic from Ch 1; VA haemodynamics deferred to Ch 13. | I Foundations | September 6, 2026 | PhysiologicalObservationalExpert opinion | Sep 6, 2026 8:52 AM | ||
12 | Not started | III VA ECMO | Sep 6, 2026 8:28 AM | ||||||
27 | Not started | V Monitoring | Sep 6, 2026 8:28 AM | ||||||
40 | Not started | VII Anticoagulation | Sep 6, 2026 8:28 AM | ||||||
19 | Not started | IV ECPR | Sep 6, 2026 8:28 AM | ||||||
48 | Not started | VIII Pharmacology | Sep 6, 2026 8:28 AM | ||||||
49 | Not started | VIII Pharmacology | Sep 6, 2026 8:28 AM |